Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Documenti analoghi

• Drain the lysosome: Development of the novel orally available autophagy inhibitor ROC-325
  di: Carew, Jennifer S., et al.
  Pubblicazione: (2017)
• The novel autophagy inhibitor ROC-325 augments the anti-leukemic activity of azacitidine
  di: Nawrocki, Steffan T., et al.
  Pubblicazione: (2019)
• Disruption of autophagic degradation with ROC-325 antagonizes renal cell carcinoma pathogenesis
  di: Carew, Jennifer S., et al.
  Pubblicazione: (2016)
• Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy
  di: Jones, Trace M., et al.
  Pubblicazione: (2020)
• Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance
  di: Nawrocki, Steffan T., et al.
  Pubblicazione: (2020)